Search results
Study Addresses Racial/Ethnic Disparities in Psoriasis Rx
Medscape· 4 hours agoBlack patients with psoriasis had the lowest rate of switching to another biologic therapy compared...
...Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA...
FOX 4 Kansas City· 2 days agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 2 days agoChinese biopharmaceutical company Innovent Biologics has reported that its Phase III CLEAR-1 study...
Innovent to take IL-23 psoriasis drug to Chinese regulators after phase 3 win
FierceBiotech· 2 days agoThe anti-IL-23 monoclonal antibody, called picankibart, hit all primary and key secondary endpoints...
At 70, Cyndi Lauper Details How She Looks and Feels Her Best Amid Chronic Illness
Prevention· 4 days agoPop icon Cyndi Lauper opens up about how she feels her best while living with a chronic condition....
Why Mindy Kaling Is Advocating for a Health Condition She Doesn't Have
SheKnows· 2 days agoMindy Kaling is no stranger to advocating for herself. Before she created hit shows like The Mindy...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 7 days agoZai Lab has dosed the first subject in a Phase II clinical trial of ZL-1102, an investigational...
10 Science-Backed Benefits of Turmeric for Skin
Prevention via Yahoo News· 12 hours agoIt has been found to aid in psoriasis healing Curcumin is believed to treat psoriasis by interfering the overproduction of skin cells that create scaly...
Ladenburg says Buy Palisade Bio stock, sees potential in PALI-2108 By Investing.com
Investing.com· 20 hours agoLadenburg says Buy Palisade Bio stock, sees potential in PALI-2108
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 6 days agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...